世界のエフェドリン産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Ephedrine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB05812)・商品コード:QYR20FB05812
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界のエフェドリン市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。エフェドリンの種類別には、タブレット、カプセル、注射に、用途別には、医療用、レクリエーション用、その他の用途に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・エフェドリンの種類別市場規模:タブレット、カプセル、注射
・エフェドリンの用途別市場規模:医療用、レクリエーション用、その他の用途
・エフェドリンの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Pfizer、Servier、Roche、Merck、Amgen、Novartis、Sanofi、Medarex、Malladi Drugs&Pharmaceuticals、GlaxoSmithKline
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Ephedrine is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia.In 2018, the global Ephedrine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ephedrine.

This study researches the market size of Ephedrine, presents the global Ephedrine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Ephedrine in key regions like North America, Europe, China, Japan and India, presents sales, revenue, market share, growth rate of Ephedrine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Servier
Roche
Merck
Amgen
Novartis
Sanofi
Medarex
Malladi Drugs&Pharmaceuticals
GlaxoSmithKline

Market Segment by Product Type
Tablet
Capsule
Injection

Market Segment by Application
Medical use
Recreational use
Other uses

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Ephedrine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Ephedrine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ephedrine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Ephedrine Market Size Growth Rate by Type
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Injection
1.4 Market Segment by Application
1.4.1 Global Ephedrine Market Share by Application (2019-2025)
1.4.2 Medical use
1.4.3 Recreational use
1.4.4 Other uses
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Ephedrine Market Size
2.1.1 Global Ephedrine Revenue 2014-2025
2.1.2 Global Ephedrine Sales 2014-2025
2.2 Ephedrine Growth Rate by Regions
2.2.1 Global Ephedrine Sales by Regions 2014-2019
2.2.2 Global Ephedrine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Ephedrine Sales by Manufacturers
3.1.1 Ephedrine Sales by Manufacturers 2014-2019
3.1.2 Ephedrine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Ephedrine Revenue by Manufacturers (2014-2019)
3.2.2 Ephedrine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Ephedrine Market Concentration Ratio (CR5 and HHI)
3.3 Ephedrine Price by Manufacturers
3.4 Key Manufacturers Ephedrine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Ephedrine Market
3.6 Key Manufacturers Ephedrine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablet Sales and Revenue (2014-2019)
4.1.2 Capsule Sales and Revenue (2014-2019)
4.1.3 Injection Sales and Revenue (2014-2019)
4.2 Global Ephedrine Sales Market Share by Type
4.3 Global Ephedrine Revenue Market Share by Type
4.4 Ephedrine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Ephedrine Sales by Application

6 North America
6.1 North America Ephedrine Breakdown Data by Company
6.2 North America Ephedrine Breakdown Data by Type
6.3 North America Ephedrine Breakdown Data by Application
6.4 North America Ephedrine Breakdown Data by Countries
6.4.1 North America Ephedrine Sales by Countries
6.4.2 North America Ephedrine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Ephedrine Breakdown Data by Company
7.2 Europe Ephedrine Breakdown Data by Type
7.3 Europe Ephedrine Breakdown Data by Application
7.4 Europe Ephedrine Breakdown Data by Countries
7.4.1 Europe Ephedrine Sales by Countries
7.4.2 Europe Ephedrine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Ephedrine Breakdown Data by Company
8.2 Asia Pacific Ephedrine Breakdown Data by Type
8.3 Asia Pacific Ephedrine Breakdown Data by Application
8.4 Asia Pacific Ephedrine Breakdown Data by Regions
8.4.1 Asia Pacific Ephedrine Sales by Countries
8.4.2 Asia Pacific Ephedrine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Ephedrine Breakdown Data by Company
9.2 Central & South America Ephedrine Breakdown Data by Type
9.3 Central & South America Ephedrine Breakdown Data by Application
9.4 Central & South America Ephedrine Breakdown Data by Countries
9.4.1 Central & South America Ephedrine Sales by Countries
9.4.2 Central & South America Ephedrine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Ephedrine Breakdown Data by Type
10.2 Middle East and Africa Ephedrine Breakdown Data by Application
10.3 Middle East and Africa Ephedrine Breakdown Data by Countries
10.3.1 Middle East and Africa Ephedrine Sales by Countries
10.3.2 Middle East and Africa Ephedrine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Ephedrine
11.1.4 Ephedrine Product Introduction
11.1.5 Pfizer Recent Development
11.2 Servier
11.2.1 Servier Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Ephedrine
11.2.4 Ephedrine Product Introduction
11.2.5 Servier Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Ephedrine
11.3.4 Ephedrine Product Introduction
11.3.5 Roche Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Ephedrine
11.4.4 Ephedrine Product Introduction
11.4.5 Merck Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Ephedrine
11.5.4 Ephedrine Product Introduction
11.5.5 Amgen Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Ephedrine
11.6.4 Ephedrine Product Introduction
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Ephedrine
11.7.4 Ephedrine Product Introduction
11.7.5 Sanofi Recent Development
11.8 Medarex
11.8.1 Medarex Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Ephedrine
11.8.4 Ephedrine Product Introduction
11.8.5 Medarex Recent Development
11.9 Malladi Drugs&Pharmaceuticals
11.9.1 Malladi Drugs&Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Ephedrine
11.9.4 Ephedrine Product Introduction
11.9.5 Malladi Drugs&Pharmaceuticals Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Ephedrine
11.10.4 Ephedrine Product Introduction
11.10.5 GlaxoSmithKline Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ephedrine Sales Channels
12.2.2 Ephedrine Distributors
12.3 Ephedrine Customers

13 Market Forecast
13.1 Global Ephedrine Sales and Revenue Forecast 2019-2025
13.2 Global Ephedrine Sales Forecast by Type
13.3 Global Ephedrine Sales Forecast by Application
13.4 Ephedrine Forecast by Regions
13.4.1 Global Ephedrine Sales Forecast by Regions 2019-2025
13.4.2 Global Ephedrine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Ephedrine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Ephedrine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Ephedrine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Ephedrine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Ephedrine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer



【掲載企業】

Pfizer、Servier、Roche、Merck、Amgen、Novartis、Sanofi、Medarex、Malladi Drugs&Pharmaceuticals、GlaxoSmithKline

★調査レポート[世界のエフェドリン産業:成長傾向・競合分析2019-2025] (コード:QYR20FB05812)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエフェドリン産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆